Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RIDAURA DIN 01916823

Status: Marketed
Holder: XEDITON PHARMACEUTICALS INC
Molecule: AURANOFIN
Available to quote

Health Canada record

Active ingredient(s)AURANOFIN 3 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCM01CB03 AURANOFIN
Original market date31-Dec-1993
Current status date17-Jun-2010
SourceHealth Canada DPD

Establishment licence of the holder

Xediton Pharmaceuticals Inc — licence 101770, currently licensed, last inspection rating C (2026-06-09).

No Canadian shortage report is currently matched to this DIN.

Notices of Compliance

NOCDateSubmissionReason
110082010-02-05New Drug Submission (NDS)Manufacturer name change
103852009-07-15New Drug Submission (NDS)Manufacturer name change
77922006-03-01New Drug Submission (NDS)MANUFACTURER NAME CHANGE
15581999-11-17New Drug Submission (NDS)
32931997-12-08New Drug Submission (NDS)

International API supply for AURANOFIN

1 active FDA Drug Master Files.

Request a quote for RIDAURA

How to read a Canadian DIN record